Health Care & Life Sciences » Pharmaceuticals | Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. | Mutual Funds

Mutual Funds that own Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Value Partners Intelligent Funds - China Convergence Fund
4,035,100
2.02%
3,424,900
1.21%
12/31/2017
Hwang Select Asia (ex Japan) Quantum Fund
1,673,600
0.84%
-2,179,600
1.3%
02/28/2018
CREF Stock Account
1,636,400
0.82%
0
0%
03/31/2018
783,000
0.39%
0
0.08%
03/31/2018
Pioneer Funds - Asia (ex-Japan) Equity
465,900
0.23%
465,900
0.49%
01/31/2018
SPDR S&P Emerging Markets Small Cap ETF
351,300
0.18%
0
0.07%
09/06/2018
314,400
0.16%
314,400
1.38%
06/30/2018
300,000
0.15%
300,000
2.7%
02/28/2018
NPB SICAV - NPB Asia (ex-Japan)
220,000
0.11%
220,000
1.31%
12/31/2017
187,700
0.09%
187,700
1.38%
06/30/2018

About Tianjin Zhongxin Pharmaceutical Group Corp.

View Profile
Address
Zhongxin Building
Tianjin Tianjin 300193
China
Employees -
Website -
Updated 07/08/2019
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.